|
Gilead Sciences Stock Price GILDCompany Description : A biopharmaceutical company which discovers, develops and commercializes therapeutics in areas of unmet medical need. url: www.gilead.com |
Name:
Gilead Sciences (MM) |
Symbol:
NASDAQ:GILD |
Stock Market:
NASDAQ Stock Market |
Type:
Common Stock |
ISIN:
|
Description:
|
| | Change (p) | Change (%) | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | -0.05 | -0.11 | 46.96 | 46.45 | 47.02 | 47.37 | 46.57 | 47.13 | 4359893 | 7:22:01 | | |
 Register for free Gilead Sciences stock prices. |
Seven Summits Research Releases Comments on Microsoft, Amazon.com, Celgene, Starwood Hotels and Gilead Sciences : CHICAGO, Oct. 19 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide.
The Seven Summits Strategic Investments Stocks To Watch Guide (go to: http://www.iotogo.com/StocksToWatch) provides...
Free Gilead Sciences Stock ChartsGilead Sciences Historical Stock Chart
 | | Gilead Sciences Monthly Stock Chart
 | Gilead Sciences Intraday stock chart
 | Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range. Get the Latest Gilead Sciences stock Price, quotes, trades and FREE Gilead Sciences stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Gilead Sciences (GILD) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards. | | Gilead Sciences News & Message Board Discussion
| Latest Gilead Sciences News Headlines | | Date | Time | Source | | | 10/20/2009 | 6:34PM | DJN | 2nd UPDATE: Gilead 3Q Net Rises 36%; Benefits From Tamiflu |
| 10/20/2009 | 6:01PM | DJN | UPDATE: Gilead 3Q Net Rises 36%; Benefits From Tamiflu |
| 10/20/2009 | 5:48PM | DJN | US EARNINGS WRAP: Yahoo, Sallie Mae Smash Profit Views |
| 10/20/2009 | 4:55PM | DJN | Gilead 3Q Profit Rises 36% On Sales Growth, Results Beat Views |
| 10/19/2009 | 9:31AM | PRNUS | Seven Summits Research Releases Comments on Microsoft, Amazon.com, Celgene, Starwood Hotels and Gilead Sciences |
| 10/16/2009 | 2:55PM | DJN | US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches |
| 10/14/2009 | 11:06AM | PRNUS | Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak |
| 10/05/2009 | 9:31AM | PRNUS | Critical Alerts for US Steel, Gilead, Dow Chemical, Banco Bradesco, and Marvel Entertainment Released by Seven Summits Research |
| 09/11/2009 | 9:31AM | PRNUS | Critical Alerts for AT&T, Gilead, Chesapeake Energy, Sallie Mae, and Marriott Released by Seven Summits Research |
| 08/14/2009 | 7:11PM | DJN | Gilead: US Requests Documents About Angina Drug |
| 08/06/2009 | 9:31AM | PRNUS | Critical Alerts for AIG, Gilead, American Airlines, Agilent Technologies, and Canadian Solar Released by Seven Summits Research |
| 07/30/2009 | 5:00PM | DJN | MARKET SNAPSHOT: As Earnings Doubts Fade, Stocks Set Sights On GDP |
|
|
Gilead Sciences Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
| Register for FREE access to the latest Gilead Sciences company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales. |
Latest Gilead Sciences Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | 6546 | 46.96 | 11/24/2009 | 4:59PM | USD |
|
|
| |